[Ip-health] MSF briefing note: Canada position on compulsory license in the context of the TRIPS waiver negotiation

Yuanqiong HU Yuanqiong.HU at geneva.msf.org
Tue Mar 9 10:40:31 PST 2021

Hi all,

I would like to share a new briefing note we produced concerning Canada's position on compulsory license at the WTO discussion on the TRIPS waiver. For your kind reference:

(also available at: https://msfaccess.org/sites/default/files/2021-03/COVID-IP-TRIPSMSF%20Canada%20Briefer%20on%20TRIPS%20Waiver-Feb%202021-ENG.pdf )<https://msfaccess.org/sites/default/files/2021-03/COVID-IP-TRIPSMSF%20Canada%20Briefer%20on%20TRIPS%20Waiver-Feb%202021-ENG.pdf>

"Both in its domestic response to COVID-19, and its global response to past pandemics, Canada has been quick to pass legislation creating tools to improve access to medicines not after careful, studied examination of evidence that these mechanisms are effective at resolving narrowly defined access problems, but on the premise that these novel tools might be of value in the response going forward. Its failure to adopt a similar approach to the WTO waiver proposal is not only unfortunate but undermines Canada’s stated goal of ending COVID-19 everywhere. Rather than continuing to insist other countries attempt to apply inadequate existing tools to the novel problem of the COVID-19 pandemic, Canada’s approach at the WTO should take a page from its domestic strategy of proactively anticipating new problems before they arise and creating new tools to address them."

Best regards,

HU Yuan Qiong, PhD
Policy Co-coordinator | Senior Legal & Policy Advisor

Médecins Sans Frontières Access Campaign | Rue de Lausanne 78, P.O. Box 1016, CH-1211 Geneve 1, Switzerland

Please consider the environment, think before printing.

More information about the Ip-health mailing list